ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,363Medicare Part D Prescriptions Filled, Including Refills

Rank: 132 out of 1121

$659K Total Retail Price of All Prescriptions

Rank: 236 out of 1121

429 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 429 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

32% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 11,308 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 910 554 S3 1 3
OMEPRAZOLE 639 465 2 6
SIMVASTATIN 552 419 3 1
AMLODIPINE BESYLATE 402 329 4 5
LEVOTHYROXINE SODIUM 402 330 4 2
FUROSEMIDE 378 291 6 7
LISINOPRIL 309 235 7 4
ZOLPIDEM TARTRATE 286 197 8 19
PRAVASTATIN SODIUM 283 229 9 14
METOPROLOL TARTRATE 280 207 10 9
BENAZEPRIL HCL 260 205 11 41
ATENOLOL 237 201 12 16
CITALOPRAM HBR 231 196 13 18
GLYBURIDE 215 154 R 14 51
DONEPEZIL HCL 183 170 15 35
RANITIDINE HCL 177 122 16 33
POTASSIUM CHLORIDE 177 149 16 12
MELOXICAM 176 151 18 22
METFORMIN HCL 174 121 19 8
HYDROCHLOROTHIAZIDE 171 137 20 10
ALLOPURINOL 167 89 21 30
SERTRALINE HCL 148 122 22 21
GABAPENTIN 127 87 23 13
WARFARIN SODIUM 124 93 24 11
METOPROLOL SUCCINATE 124 86 24 23
CLOPIDOGREL 114 106 26 27
LOSARTAN POTASSIUM 112 89 27 17
MIRTAZAPINE 109 72 28 56
DIGOXIN 105 87 29 59
OXYBUTYNIN CHLORIDE 104 78 30 128
NEXIUM 100 80 31 24
CARVEDILOL 98 82 32 20
LEVOFLOXACIN 95 71 33 79
PLAVIX 95 77 33 42
NAMENDA 95 91 33 53
TRAZODONE HCL 94 46 36 40
ALENDRONATE SODIUM 94 73 36 37
AMITRIPTYLINE HCL 93 63 R 38 61
CEPHALEXIN 93 79 38 111
METOCLOPRAMIDE HCL 91 49 40 120
CIPROFLOXACIN HCL 91 67 40 57
CLONIDINE HCL 90 56 42 39
ATORVASTATIN CALCIUM 89 86 43 15
ESTRADIOL 88 54 R 44 95
TRIAMTERENE-HCTZ 83 58 45 38
LOVASTATIN 83 62 45 26
TERAZOSIN HCL 83 60 45 130
FLUOXETINE HCL 81 56 48 60
LANTUS 81 56 48 52
TRAMADOL HCL 80 77 50 25
PREDNISONE 80 64 50 43
NOVOLIN 70-30 77 77 52 235
METFORMIN HCL ER 76 57 53 47
BENAZEPRIL-HYDROCHLOROTHIAZIDE 75 50 54 153
TORSEMIDE 74 65 55 155
GLIMEPIRIDE 72 38 56 34
DOXYCYCLINE HYCLATE 69 40 57 103
PROAIR HFA 69 29 57 48
CYMBALTA 69 34 57 50
LEVETIRACETAM 69 58 57 125
FAMOTIDINE 67 33 61 63
PROMETHAZINE HCL 67 20 R 61 67
CARISOPRODOL 66 17 R 63 72
LYRICA 65 44 64 76
BUPROPION HCL SR 65 42 64 205
ISOSORBIDE MONONITRATE ER 65 53 64 62
AMLODIPINE BESYLATE-BENAZEPRIL 64 60 67 65
SPIRONOLACTONE 61 42 68 54
CYCLOBENZAPRINE HCL 60 23 R 69 83
KLOR-CON 10 58 38 70 69
POLYETHYLENE GLYCOL 3350 58 36 70 70
INSULIN SYRINGE 57 39 72 77
FLUTICASONE PROPIONATE 56 29 73 36
PRIMIDONE 56 56 73 217
ROPINIROLE HCL 56 47 73 91
JANUVIA 56 52 73 81
OXYCODONE HCL-ACETAMINOPHEN 56 38 S2 73 86
ESCITALOPRAM OXALATE 55 44 78 94
OLANZAPINE 53 51 79 181
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.